Amazon’s internal documents warn employees not to use generative AI models for work
It’s unclear who owns the information that goes in and comes out of a genAI tool, the company warns in internal guidances.
It’s unclear who owns the information that goes in and comes out of a genAI tool, the company warns in internal guidances.
The mini colons replicate both the physical structure and cellular diversity in the colon in both healthy and diseased states.
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
Matings between two species are often evolutionary dead ends. This one birthed a new species
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
She promised investors an easy windfall. Then it all came crashing down.
Two distinguished neuroscientists distill general principles from more than a century of scientific study, “reverse engineering” the brain to understand …
My name is Ricardo Lopes, and I’m from Portugal. Thank you for visiting my podcast. Over the past few years, I have conducted and released…
Maruwa, which builds ceramics for circuit boards and semiconductors, has seen its shares double over the past year.
Synthesia’s new technology is impressive but raises big questions about a world where we increasingly can’t tell what’s real.
Synthesia’s new technology is impressive but raises big questions about a world where we increasingly can’t tell what’s real.